Increased expression of CYP1A1 and CYP1B1 in ovarian/peritoneal endometriotic lesions

Reproduction

Volumn 151, Issue 6, 2016, Pages 683-692

  Piccinato, Carla A ^a,b   Neme, Rosa M ^a,c   Torres, Natália ^a   Sanches, Lívia Renta ^a   Derogis, Priscilla Bento Mattos Cruz ^a   Brudniewski, Heloísa F ^a,c   Silva, Úlio C Rosa E ^b   Ferriani, Rui A ^b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Centro de Endometriose São Paulo   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; MESSENGER RNA; CYP1A1 PROTEIN, HUMAN; CYP1B1 PROTEIN, HUMAN; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1;

ADULT; AEROBIC METABOLISM; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYP1A1 GENE; CYP1B1 GENE; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; ESTROGEN METABOLISM; FEMALE; GENE; GENE EXPRESSION; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; CASE CONTROL STUDY; COMPARATIVE STUDY; ENDOMETRIUM; GENETICS; METABOLISM; OVARY DISEASE; PERITONEAL DISEASE;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1B1; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; OVARIAN DISEASES; PERITONEAL DISEASES;

EID: 84971569643     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-15-0581     Document Type: Article

References (31)

1. Aghajanova L, Velarde MC & Giudice LC 2010 Altered gene expression profiling in endometrium: evidence for progesterone resistance. Seminars in Reproductive Medicine 28 51-58. (doi:10.1055/s-0029-1242994)
2. Bofinger DP, Feng L, Chi LH, Love J, Stephen FD, Sutter TR, Osteen KG, Costich TG, Batt RE, Koury ST et al. 2001 Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant cultures of human endometrium. Toxicological Sciences 62 299-314. (doi:10.1093/ toxsci/62.2.299)
3. Bulun SE, Cheng YH, Yin P, Imir G, Utsunomiya H, Attar E, Innes J & Julie Kim J 2006 Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Molecular and Cellular Endocrinology 248 94-103. (doi:10.1016/j.mce.2005.11.041)
4. Cai LY, Izumi S, Suzuki T, Goya K, Nakamura E, Sugiyama T & Kobayashi H 2011 Dioxins in ascites and serum of women with endometriosis: a pilot study. Human Reproduction 26 117-126. (doi:10.1093/humrep/deq312)
5. Ciolino HP & Yeh GC 1999 Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Molecular Pharmacology 56 760-767.
6. Eskenazi B & Warner ML 1997 Epidemiology of endometriosis. Obstetrics and Gynecology Clinics of North America 24 235-258. (doi:10.1016/ S0889-8545(05)70302-8)
7. Ferrero S, Venturini PL, Ragni N, Camerini G & Remorgida V 2009 Pharmacological treatment of endometriosis: experience with aromatase inhibitors. Drugs 69 943-952. (doi:10.2165/00003495-200969080-00001)
8. Giudice LC 2010 Clinical practice. Endometriosis. New England Journal of Medicine 362 2389-2398. (doi:10.1056/NEJMcp1000274)
9. Giudice LC & Kao LC 2004 Endometriosis. Lancet 364 1789-1799. (doi:10.1016/S0140-6736(04)17403-5)
10. Hakkola J, Pasanen M, Pelkonen O, Hukkanen J, Evisalmi S, Anttila S, Rane A, Mantyla M, Purkunen R, Saarikoski S et al. 1997 Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 18 391-397. (doi:10.1093/carcin/18.2.391)
11. Hevir N, Sinkovec J & Rizner TL 2011 Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT. Molecular and Cellular Endocrinology 331 158-167. (doi:10.1016/j.mce.2010.09.011)
12. Hevir N, Ribic-Pucelj M & Rizner TL 2013 Disturbed balance between phase I and II metabolizing enzymes in ovarian endometriosis: a source of excessive hydroxy-estrogens and ROS? Molecular and Cellular Endocrinology 367 74-84. (doi:10.1016/j.mce.2012.12.019)
13. Huhtinen K, Desai R, Stahle M, Salminen A, Handelsman DJ, Perheentupa A & Poutanen M 2012 Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels. Journal of Clinical Endocrinology & Metabolism 97 4228-4235. (doi:10.1210/jc.2012-1154)
14. Huhtinen K, Saloniemi-Heinonen T, Keski-Rahkonen P, Desai R, Laajala D, Stahle M, Hakkinen MR, Awosanya M, Suvitie P, Kujari H et al. 2014Intra-tissue steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions. Journal of Clinical Endocrinology & Metabolism 99 E2188-2197. (doi:10.1210/jc.2014-1913)
15. Klemmt PAB, Carver JG, Koninckx P, McVeigh EJ & Mardon HJ 2007 Endometrial cells from women with endometriosis have increased adhesion and proliferative capacity in response to extracellular matrix components: towards a mechanistic model for endometriosis progression. Human Reproduction 22 3139-3147. (doi:10.1093/ humrep/dem262)
16. Koninckx PR, Kennedy SH & Barlow DH 1998 Endometriotic disease: the role of peritoneal fluid. Human Reproduction Update 4 741-751. (doi:10.1093/humupd/4.5.741)
17. Lee AJ, Kosh JW, Conney AH & Zhu BT 2001 Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. Journal of Pharmacology and Experimental Therapeutics 298 420-432.
18. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 402-408. (doi:10.1006/meth.2001.1262)
19. Martinez-Zamora MA, Mattioli L, Parera J, Abad E, Coloma JL, van Babel B, Galceran MT, Balasch J & Carmona F 2015 Increased levels of dioxin-like substances in adipose tissue in patients with deep infiltrating endometriosis. Human Reproduction 30 1059-1068. (doi:10.1093/ humrep/dev026)
20. Martucci CP & Fishman J 1993 P450 enzymes of estrogen metabolism. Pharmacology & Therapeutics 57 237-257.
21. Murray GI, Melvin WT, Greenlee WF & Burke MD 2001 Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annual Review of Pharmacology and Toxicology 41 297-316.
22. Pavek P & Dvorak Z 2008 Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Current Drug Metabolism 9 129-143. (doi:10.2174/138920008783571774)
23. Piccinato CA, Neme RM, Torres N, Sanches LR, Derogis PB, Brudniewski HF, Rosa ESJC & Ferriani RA 2016 Effects of steroid hormone on estrogen sulfotransferase and on steroid sulfatase expression in endometriosis tissue and stromal cells. Journal of Steroid Biochemistry and Molecular Biology 158 117-126. (doi:10.1016/j.jsbmb.2015.12.025)
24. Rochat B, Morsman JM, Murray GI, Figg WD & McLeod HL 2001 Human CYP1B1 and anticancer agent metabolism: mechanism for tumorspecific drug inactivation? Journal of Pharmacology and Experimental Therapeutics 296 537-541.
25. Singh MN, Stringfellow HF, Taylor SE, Ashton KM, Ahmad M, Abdo KR, El-Agnaf OM, Martin-Hirsch PL & Martin FL 2008 Elevated expression of CYP1A1 and gamma-SYNUCLEIN in human ectopic (ovarian) endometriosis compared with eutopic endometrium. Molecular Human Reproduction 14 655-663. (doi:10.1093/molehr/gan056)
26. Tsai SJ, Wu MH, Lin CC, Sun HS & Chen HM 2001 Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. Journal of Clinical Endocrinology and Metabolism 86 5765-5773. (doi:10.1210/jcem.86.12.8082)
27. Tsuchiya Y, Nakajima M & Yokoi T 2005 Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Letters 227 115-124. (doi:10.1016/j.canlet.2004.10.007)
28. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A & Speleman F 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3 RESEARCH0034. (doi:10.1186/gb-2002-3-7-research0034)
29. Waxman DJ 1988 Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochemial Pharmacology 37 71-84. (doi:10.1016/0006-2952(88)90756-3)
30. Zanger UM & Schwab M 2013 Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics 138 103-141.
31. Zhu BT & Conney AH 1998 Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19 1-27. (doi:10.1093/ carcin/19.1.1)